fda statement bpc-157 compounding safety risks BREAKING #PEPTIDE NEWS: has officially passed the vote needed for recommendation to the bulks list. #bpc157 atta boy @gabrielalizaidy The Food and Drug Administration's

The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link FDA Discusses Peptide Bulk Substances BPC 157 and More Hillary Lin, MD posted on the topic LinkedIn FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition

SKU: 42744338184 · From clintoncounty708.com